Hypertension: Potential Player in Cardiovascular Disease Incidence in Preeclampsia

Parya Amini1, Mehran Amrovani2, Zohre Saleh Nassaj3

  • 1Atherosclerosis Research Center, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran.

Insights

Preeclampsia (PE) is a serious pregnancy complication affecting 3-7% of pregnancies and increasing cardiovascular disease (CVD) risk. Understanding blood pressure regulation pathways can lead to targeted therapies to reduce mortality in mothers with PE.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Research
  • Molecular Biology

Background:

  • Preeclampsia (PE) affects 3-7% of pregnancies, posing significant risks including preterm delivery and maternal mortality.
  • Elevated blood pressure in PE is linked to increased cardiovascular disease (CVD) risk and mortality.
  • Key factors regulating blood pressure include Atrial Natriuretic Peptide (ANP), the Renin-Angiotensin system, and nitric oxide (NO).

Purpose of the Study:

  • To investigate the signaling pathways involved in blood pressure regulation by ANP, Renin-Angiotensin system, and NO in the context of preeclampsia.
  • To identify potential therapeutic targets for managing hypertension in PE.
  • To reduce the risk of CVD and mortality associated with preeclampsia.

Main Methods:

  • Literature review of studies on preeclampsia pathophysiology.
  • Analysis of molecular mechanisms underlying blood pressure regulation by ANP, Renin-Angiotensin system, and NO.
  • Identification of signaling pathways implicated in PE-related hypertension.

Main Results:

  • The study highlights the complex interplay of ANP, Renin-Angiotensin system, and NO in modulating blood pressure during pregnancy.
  • Specific signaling pathways contributing to hypertension in PE were identified.
  • These pathways represent potential targets for novel therapeutic interventions.

Conclusions:

  • Targeted therapies focusing on identified signaling pathways can effectively reduce blood pressure in PE patients.
  • Effective blood pressure management in PE can mitigate the long-term risk of cardiovascular disease.
  • Further research into these pathways may lead to improved treatment strategies and reduced maternal mortality in preeclampsia.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
67
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.2K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
123
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
109
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
58